HAE
Haemonetics Stock Analysis
AI Rating
- Quality8/10
- Growth↑ 6/10
- Value↓ 4/10
HAE Growth
- Revenue Y/Y↓ -4.02%
- EPS Y/Y↑ 42.58%
- FCF Y/Y↑ 148.79%
HAE Profitability
- Gross margin ↑ 59.40%
- EPS margin↑ 13.30%
- ROIC 5Y↓ 11.26%
HAE Risk
- Debt / Equity↓ 1.3
- Debt / FCF↓ 3.3
- Interest coverage↑ 10.5
Haemonetics stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.